![Pepper Landson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pepper Landson is the founder of Praetego, Inc. as Chief Executive Officer, founded in 2017.
Former job at Medpace Research, Inc. as Vice President-Clinical Operations.
Education includes undergraduate degrees from Syracuse University and Marymount University.
| Unternehmen | Position | Beginn |
|---|---|---|
Praetego, Inc.
 Praetego, Inc. BiotechnologyHealth Technology Engages in development of amadorin inhibitors for diabetic complications | Vorstandsvorsitzender | 01.01.2017 |
| Unternehmen | Position | Ende |
|---|---|---|
| NEPHROGENEX INC | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
Syracuse University
 Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Marymount University
 Marymount University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medpace Research, Inc.
 Medpace Research, Inc. Medical DistributorsDistribution Services Develops drugs and novel therapies for kidney diseases | Distribution Services |
Praetego, Inc.
Praetego, Inc. BiotechnologyHealth Technology Engages in development of amadorin inhibitors for diabetic complications | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
